Sort
146,196 grants matching “diabetes”
Gut Microbiota and Cardiometabolic Diseases
$2,445,300Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · P01 · FY2019 · HL
The ISCHEMIA-CKD Trial-CCC-Lead Application
$2,443,785Sripal Bangalore · New York University School Of Medicine · U01 · FY2015 · HL
Diabetes and Periodontics Trial - Administrative Center/Study Chair
$2,443,149Steven P Engebretson · State University New York Stony Brook · U01 · FY2010 · DE
Applying Bioinformatics to Research in Immune, Muscle, and Bone Diseases
$2,442,797Hong-Wei Sun · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2024 · AR
P-CARRS-BRAIN: Multi-domain (genetic, socio-behavioral, vascular) risk factors and prediction of Alzheimerâs Disease continuum in South Asians in India
$2,442,538Kabayam M Venkat Narayan · Emory University · R01 · FY2025 · AG
Nutrition and Superfund Chemical Toxicity
$2,442,381Bernhard Hennig · University Of Kentucky · P42 · FY2015 · ES
Nutrition and Superfund Chemical Toxicity
$2,442,381Bernhard Hennig · University Of Kentucky · P42 · FY2014 · ES
Mitochondrial Quality in Cardioprotection: Overcoming Co-Morbidities
$2,442,081Roberta A. Gottlieb · Cedars-Sinai Medical Center · P01 · FY2017 · HL
Nutrition and Superfund Chemical Toxicity
$2,441,545Bernhard Hennig · University Of Kentucky · P42 · FY2019 · ES
Mitochondrial Quality in Cardioprotection: Overcoming Co-Morbidities
$2,441,087Roberta A. Gottlieb · Cedars-Sinai Medical Center · P01 · FY2016 · HL
Alzheimer's Disease Research Center - Overall
$2,440,109Scott A Small · Columbia University Health Sciences · P50 · FY2015 · AG
Trial to Assess Chelation Therapy 2 (TACT2) DCC Competing Renewal
$2,439,270Daniel B Mark · Duke University · U24 · FY2022 · AT
GENERAL CLINICAL RESEARCH CENTER
$2,439,173University Of Vermont &St Agric College · M01 · FY2000 · RR
Trial to Reduce IDDM in the Genetically at Risk- study
$2,438,769Mikael Knip · University Of Helsinki · U01 · FY2009 · HD
The Louisiana Clinical Center of Nutrition for Precision Health (LA-NPH)
$2,437,881Eric Ravussin · Lsu Pennington Biomedical Research Ctr · UG1 · FY2024 · HD
AIDS Linked to the IntraVenous Experience (ALIVE)
$2,437,098Shruti H Mehta · Johns Hopkins University · U01 · FY2023 · DA
Protection of Ischemic Myocardium
$2,437,090Roberto Bolli · University Of Louisville · P01 · FY2013 · HL
AIDS Linked to the IntraVenous Experience (ALIVE)
$2,436,595Shruti H Mehta · Johns Hopkins University · U01 · FY2024 · DA
The Early Life Exposome and Childhood Health - The Colorado Healthy Start 3 Cohort Study
$2,436,580Dana Dabelea · University Of Colorado Denver · UH3 · FY2019 · OD
Pannexin Channels In Vascular Physiology & Inflammation
$2,436,333Douglas A Bayliss · University Of Virginia · P01 · FY2022 · HL
Pannexin Channels In Vascular Physiology & Inflammation
$2,436,333Douglas A Bayliss · University Of Virginia · P01 · FY2021 · HL
Pannexin Channels In Vascular Physiology & Inflammation
$2,436,333Douglas A Bayliss · University Of Virginia · P01 · FY2023 · HL
Glycoconjugates and Cardiovascular Disease
$2,436,266Gerald Warren Hart · Johns Hopkins University · P01 · FY2011 · HL
Asian Cohort for Alzheimer's Disease (ACAD)
$2,435,808Li-San Wang · University Of Pennsylvania · R56 · FY2021 · AG
Autocoids in Hypertension: Pathogenesis and End Organ Damage
$2,435,234Oscar A. Carretero · Henry Ford Health System · P01 · FY2015 · HL